Literature DB >> 1364051

Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms.

T Ashizawa1, J F Hejtmancik, J Liu, M B Perryman, H F Epstein, D D Koch.   

Abstract

To determine diagnostic value of lens opacities in myotonic dystrophy (DM), we examined 98 at-risk members of 9 DM kindreds. Haplotype analysis of restriction fragment length polymorphisms (RFLPs) using ApoC2, CKMM, and pEFD4.2 supported the diagnosis of DM in 33 and excluded the diagnosis in 51 members. The sensitivities of bilateral iridescent lens opacities, posterior cortical lens opacities, orbicularis oculi weakness, low intraocular pressure, ptosis, and ocular myotonia were 46.7, 50.0, 60.6, 59.3, 51.5, and 3.0%, while their specificities were 100.0, 100.0, 98.0, 94.1, 96.1, and 100.0%, respectively. A peripheral pigmentary degeneration and central macular lesions of retina were not found on indirect fundoscopy. In 86.2% of DM patients, bilateral iridescent lens opacities, posterior cortical lens opacities, or both were present. Unilateral iridescent lens opacities occurred in only 3 of our DM patients, and 2 of non-DM relatives showed a few unilateral iridescent particles. Posterior cortical lens opacities in DM patients always affected both eyes in this series. We conclude that 1) bilateral iridescent lens opacities and posterior cortical lens opacities are highly specific for DM and useful for establishing clinical diagnosis of DM, 2) unilateral iridescent lens opacities are infrequent in DM and are seen in some non-DM members, and 3) ocular myotonia and clinical retinopathies are rare in DM.

Entities:  

Mesh:

Year:  1992        PMID: 1364051     DOI: 10.1002/ajmg.1320420113

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

Review 1.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

2.  Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)?

Authors:  C Abbruzzese; R Krahe; M Liguori; D Tessarolo; M J Siciliano; T Ashizawa; M Giacanelli
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

3.  Cataract and myotonic dystrophy: the role of molecular diagnosis.

Authors:  W Reardon; J C MacMillan; J Myring; H G Harley; S A Rundle; L Beck; P S Harper; D J Shaw
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

4.  Ascertainment of myotonic dystrophy through cataract by selective screening.

Authors:  A Kidd; P Turnpenny; K Kelly; C Clark; W Church; C Hutchinson; J C Dean; N E Haites
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

5.  Myotonic dystrophy: relative sensitivity of symptoms signs and abnormal investigations.

Authors:  M Avaria; V Patterson
Journal:  Ulster Med J       Date:  1994-10

Review 6.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.